Adam Green, MD
Pediatric Hematology / Oncology
Locations
Practice Locations
Children's Hospital Colorado Anschutz Medical Campus
720-777-1234
Provider Expertise
Clinical Interest for Patients
I help lead national clinical trials and give second opinions for other institutions for pediatric high-grade glioma, including diffuse intrinsic pontine glioma (DIPG), diffuse midline glioma, and radiation-induced glioma. I also specialize in the diagnosis and management of other childhood tumors of the brain and spinal cord.
Care Philosophy
I am committed to providing exceptional child- and family-centered care to my patients. I strive to communicate information truthfully to families at all times, and in an age-appropriate way to patients throughout childhood. As part of a team that includes physicians, advanced practice practitioners, nurses, social workers, and others, I aim to provide the highest quality, most innovative care to all patients from Colorado and beyond, to maximize cure rates and minimize adverse effects of treatment.
Specialties
- Pediatric Hematology / Oncology ( 2015 )
- Pediatrics ( 2010 )
Conditions & Treatments
-
Cancers
Brain Cancer, Pediatric Cancer
-
Child and Teen Health
-
Brain and Nervous System
Brain Tumors
Interests & Activities
Personal Interests
Spending time with my wife and three children, playing piano, singing, road cycling, running, and tennis.
Volunteer Activities
I enjoy educating the community on childhood cancer research and advocating for our patients. I am also a volunteer youth baseball coach.
Education & Training
Medical Schools
MD, New York University School of Medicine (2006)
Undergraduate Schools
BA, Dartmouth College (NH) (2002)
Internships
University of Colorado (Children's Hospital Colorado) Program (2007)
Residency Program
University of Colorado (Children's Hospital Colorado) Program (2010)
University of Colorado (Children's Hospital Colorado) Program (2009)
Fellowships
Dana-Farber Cancer Institute/Boston Children’s Hospital/Harvard Medical School Program (2013)
Professional Memberships
Children's Oncology Group, Member, CNS Committee
Society for Neuro-Oncology, Member
University of Colorado Cancer Center, Full Member
Research & Grants
Grants
R01: Determining the Origins and Vulnerabilities of Pediatric Treatment-Induced Gliomas (2024)
Research Interests for Patients
My research focuses on novel targets and therapies for pediatric high-grade glioma, including diffuse midline glioma, diffuse hemispheric glioma, and radiation-induced glioma. In my lab, we work to discover and exploit innovative, rational targets in these tumors, and to bring novel treatments against these targets through laboratory models of these diseases to early-phase clinical trials. We are also interested in combination therapy, resistance to therapy, and methods to bypass the blood-brain barrier. I also have a separate research effort investigating and addressing demographic, socioeconomic, and geographic disparities in pediatric cancer outcomes.
information for referring providers
Referral Contact Phone
Referring Patients Link
Clinical Interests for Referring Providers
I help lead national clinical trials and give second opinions for other institutions for pediatric high-grade glioma, including diffuse intrinsic pontine glioma (DIPG), diffuse midline glioma, and radiation-induced glioma. I also specialize in the diagnosis and management of other childhood tumors of the brain and spinal cord.
Research Interest for Referring Providers
My research focuses on novel targets and therapies for pediatric high-grade glioma, including diffuse midline glioma, diffuse hemispheric glioma, and radiation-induced glioma. In my lab, we work to discover and exploit innovative, rational targets in these tumors, and to bring novel treatments against these targets through laboratory models of these diseases to early-phase clinical trials. We are also interested in combination therapy, resistance to therapy, and methods to bypass the blood-brain barrier. I also have a separate research effort investigating and addressing demographic, socioeconomic, and geographic disparities in pediatric cancer outcomes.
